KLRD1 and urinary bladder neoplasm: Binding of Gal-3 to another ligand of the NK cell receptor, MUC-1 via the core2 O-glycans of MUC-1 impairs the interaction of metastatic human bladder tumor cells with human NK cells, leading to escape from NK cell cytotoxicity [198].